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Abstract
Background: DNA methylation of CpG sites on genetic loci has been linked to increased risk of asthma in children
exposed to elevated ambient air pollutants (AAPs). Further identification of specific CpG sites and the pollutants
that are associated with methylation of these CpG sites in immune cells could impact our understanding of asthma
pathophysiology. In this study, we sought to identify some CpG sites in specific genes that could be associated
with asthma regulation (Foxp3 and IL10) and to identify the different AAPs for which exposure prior to the blood
draw is linked to methylation levels at these sites. We recruited subjects from Fresno, California, an area known for
high levels of AAPs. Blood samples and responses to questionnaires were obtained (n = 188), and in a subset of
subjects (n = 33), repeat samples were collected 2 years later. Average measures of AAPs were obtained for 1, 15,
30, 90, 180, and 365 days prior to each blood draw to estimate the short-term vs. long-term effects of the AAP
exposures.
Results: Asthma was significantly associated with higher differentially methylated regions (DMRs) of the Foxp3
promoter region (p = 0.030) and the IL10 intronic region (p = 0.026). Additionally, at the 90-day time period (90 days
prior to the blood draw), Foxp3 methylation was positively associated with NO2, CO, and PM2.5 exposures (p = 0.001,
p = 0.001, and p = 0.012, respectively). In the subset of subjects retested 2 years later (n = 33), a positive association
between AAP exposure and methylation was sustained. There was also a negative correlation between the average
Foxp3 methylation of the promoter region and activated Treg levels (p = 0.039) and a positive correlation between
the average IL10 methylation of region 3 of intron 4 and IL10 cytokine expression (p = 0.030).
Conclusions: Short-term and long-term exposures to high levels of CO, NO2, and PM2.5 were associated with
alterations in differentially methylated regions of Foxp3. IL10 methylation showed a similar trend. For any given
individual, these changes tend to be sustained over time. In addition, asthma was associated with higher
differentially methylated regions of Foxp3 and IL10.
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Background
Asthma is the most frequent chronic disease in children
[1], and its prevalence continues to increase, raising glo-
bal public health concerns [2–4]. Previous studies found
that high prenatal ambient air pollutant (AAP) exposure
alters epigenetic programming in utero [5] and that
children are at greater risk of developing asthma when
exposed to higher concentrations of AAPs [6]. This
further raises concern and increases the urgency of
understanding the relationship between AAP exposures
and asthma and finding effective ways to prevent, treat,
and/or cure asthma. Although the mechanisms by which
exposures to AAPs increase asthma prevalence remain
poorly understood, evidence suggests that AAPs can
mediate T cell polarization and cytokine dysregulation
via epigenetic modifications [7–10].
DNA methylation at least partially controls the expres-
sion of certain key genes that are known to be involved in
immune tolerance [11–13]. We previously demonstrated
that exposure in children to high levels of polycyclic
aromatic hydrocarbons (PAHs), a component of AAPs, is
associated with higher overall percent methylation of the
transcriptional regulatory region of the forkhead box tran-
scription factor 3 (Foxp3) locus [8]. In a subsequent study,
in addition to the presence of higher Foxp3 methylation
levels, we found that exposure to higher levels of PAHs is
associated with decreased expression of IL10, an anti-
inflammatory cytokine. These associations were stronger
in children with asthma, suggesting disease-linked effects
[14]. Other studies have also associated air pollution with
other immune parameters, such as the association of ex-
posure to NOx with decreases in IL10 cytokine expression
and exposure to diesel exhaust with higher differentially
methylated regions (DMRs) of Foxp3 [15]. A recent review
of ambient air pollutants (AAPs), epigenetic regulation,
and asthma highlights the challenge that asthma is hetero-
geneous, responsiveness to traffic-related air pollution,
and may be a distinct phenotype [16]. In addition, a study
by Clifford et al. [17] found DNA methylation changes
after diesel exhaust exposure in more than 500 CpG sites
in the bronchial epithelial cells. Finally, AAPs and DNA
methylation have been linked to other health problems,
such as cardiovascular disease [18].
We sought to identify CpG sites in the Foxp3 and IL10
genes that have higher DMRs in children with asthma
exposed to AAPs. Our primary hypothesis was that ex-
posure to high levels of CO, O3, NO2, and PM2.5 would
be associated with higher DMRs within the Foxp3 gene
and the intron 4 region of the IL10 gene. The Foxp3 gene
regulates transcription of Tregs, and the Il10 gene regu-
lates transcription of various cell types, including CD4+ T
cell populations, because it has been shown to act as an
enhancer element [19]. In addition, our secondary hypoth-
eses were that methylation would be sustained following
continued exposure to these pollutants and that Treg
levels would be negatively associated with Foxp3 methyla-
tion at specific CpG loci in the enhancer and promoter
regions.
Methods
Subjects
We recruited subjects from Fresno, California, where
there is consistently high AAP. According to the 2017
American Lung Association “State of the Air” report,
Fresno ranked third in the country for year-round and
short-term particle pollution and O3 exposure [20].
Fresno County also has a high childhood asthma preva-
lence in comparison to other counties in California (24
vs. 17%, ages 5–17) [21]. Recruiting from the Fresno
Unified School district from 2010 to 2015 resulted in a
convenience sample of 198 children with complete data,
188 of which were included in the analysis after quality
control, with a median age of 14.7 years. In addition, we
retested 33 subjects after approximately 2 years (mean
820 days, SD 243 days; again, as a convenience sample).
At each clinical visit, information on BMI, a detailed
health and general history questionnaire, and blood sam-
ples were obtained. Subjects were excluded if they had
taken oral immunosuppressants within 5 days of the
blood draw, had a history of allergen immunotherapy
within 1 year of the clinical visit, had a chronic disease
other than allergies or asthma, or had an acute infection.
In addition, no blood specimen was taken during an
infection, sickness, or during the use of oral steroids.
Subjects with asthma were defined by the participant’s
report of a physician’s diagnosis of current asthma.
Secondhand smoke exposure (SHS) was defined as
exposure to cigarette smoke from other household
members. Participant smoking was defined as smoking
more than 100 cigarettes in their lifetime.
Collection and processing of blood specimens
Human peripheral blood mononuclear cells (PBMCs)
and plasma were extracted from the blood via Ficoll pro-
cedure and stored in liquid nitrogen and at − 80 °C as
per published techniques [22].
Methylation analysis
We first selected CpG sites within the upstream pro-
moter (− 138, − 126, − 77, − 65, − 58, and − 15) and
enhancer (− 4506, − 4500, − 4494, and − 4484) regions of
Foxp3 (on the X chromosome) located on the human
genome (hg38) chrX at nucleotides 49264838, 49264826,
49264777, 49264765, 49264758, 49264715, and 49269206,
49,69200, 49269194, 49269184, respectively, and within
the intron 4 region of IL10 (+ 2888, + 2907, + 2921, +
3261, + 3265, and + 3281 on chromosome 1), located
on the human genome (hg38) chr1 at nucleotides
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206769607, 206769588, 206769574, 206769234, 206769
230, 206769214, respectively, as these sites have been
shown in the literature to be key in modulating regula-
tory T cell (Treg) response and overall immune toler-
ance [11, 19, 23]. We then examined associations
between exposures to CO, O3, NO2, and PM2.5 and
methylation levels at these CpG sites. To determine
whether methylation of CpG sites is maintained with
long-term exposure, we repeated measurements on a
subset of samples obtained at approximately 2 years
after the initial blood samples were obtained. Methyla-
tion analysis using the pyrosequencing approach was
performed on the following gene loci: ten CpG sites for
Foxp3 and six CpG sites for IL10. Bisulfite modification
and subsequent DNA amplification of specific CpG
regions within the Foxp3 and IL10 genes were con-
ducted by PCR using the different pairs of primers for
each region enumerated in Additional file 1: Table S1.
Please see Additional file 1 for further details.
CyTOF mass cytometry
We also examined Treg, Foxp3, and IL10 protein expres-
sion in a subset of the subjects using mass cytometry
(CyTOF). CyTOF uses antibodies tagged with heavy metal
ions and allows for identifying many more cell markers in
a single sample than flow cytometry and without issues of
spectral overlap. Here, we performed CyTOF on a
randomly selected subset of subjects (n = 74; 24.3% asth-
matics, 75.7% non-asthmatics) for which additional blood
was available from the same blood draw as that used for
methylation analysis to assess for cell composition differ-
ences. Briefly, PBMCs were thawed, stimulated for 4 h
with 20 ng/mL phorbol myristate acetate + 1 μg/mL iono-
mycin (PMA-ION), and stained for surface markers, intra-
cellular markers, and transcription factors using CyTOF.
Please see Additional file 1 for further details.
Cell composition analysis
Nine cell subtypes were measured by gating on cell sur-
face markers obtained from the CyTOF analysis: B Cells,
monocytes, CD3+ cells, CD4+, CD8+, Th17 cells, Tregs,
Th1, and Th2 cells. The cell counts were converted into
non-overlapping proportions, with an additional miscel-
laneous category (the remaining fraction of unmeasured
cell types, typically < 5%) accounted for to normalize the
distribution to 100%. The resulting cell distributions were
compared between the asthmatic and healthy groups and
used as covariates to confirm the reproducibility of differ-
ences in methylation (see Additional file 1: Table S2).
Ambient air pollution exposure estimation
Exposure to AAPs was estimated using hourly concentra-
tion data [24] of four common pollutants (CO, O3, NO2,
and PM2.5) measured at four air quality monitoring stations
located within Fresno city limits. These data were acquired
from the US Environmental Protection Agency’s Air Quality
System online database (https://www.epa.gov/aqs).
In order to capture both the spatial and temporal
variation in the AAP exposure of each participant, we
computed an index of the average outdoor residential
AAP exposure for each individual using inverse distance
weighting (IDW) [25, 26] of AAP measurements from
the air quality monitoring stations according to their dis-
tance from each participant’s residence. For each blood
sample and air pollutant, exposure was defined as the
mean of the IDW values over the given time period
(1, 15, 30, 90, 180, or 365 days) before the sample
was taken. See online Additional file 1 for further details
of these data processing choices.
Statistical analysis
Statistical analysis was performed using the R statistical
computing software (R 3.4.1). We used linear regression
to adjust methylation values for sex, age, and BMI. Using
multivariate linear regression, we evaluated associations
of resulting residuals with asthma status and ambient air
pollution.
Due to the presence of related subjects within our
study, we also considered linear mixed-effects models fit
using generalized least squares, as implemented in the
“gls” function in the “nlme” R package (version 3.1.131)
for non-linear mixed-effects models. Unless explicitly
stated otherwise, the results from fixed-effects models
are described in the main text, and the results from
mixed-effects models are described in Additional file 1.
Detailed descriptions of all analyses are available in
Additional file 1, along with de-identified data, exposure
data, and R code (see Additional files 2, 3, 4, and 5).
Multivariate linear regression was repeated on a ran-
dom subset of the data for which CyTOF-derived cell
counts were obtained. The proportions of different cell
types were incorporated into the model to adjust for any
differences. Additionally, we performed t tests for each cell
type to look for statistically significant differences in cell
distribution. Family-wise multiple testing correction was
performed by using the Benjamini-Hochberg procedure
[27] with a false discovery rate of 0.05.
Results
Subject characteristics
For the 188 children (50% female, 50% male) included in
the study analysis, the median age (quartile 1; quartile 3)
was 14.68 years (12.98; 16.87). Median body mass
index (BMI) (quartile 1; quartile 3) was 21.81 kg/m2
(18.97; 26.28). No significant differences in these vari-
ables (p > 0.05) were seen between the two groups
(35.6% asthmatics vs. 64.4% healthy individuals, Table 1).
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Air pollution
Exposures to pollution were averaged over 1, 15, 30, 90,
180, and 365 days prior to each convenience sampling
blood draw. All subjects lived within 10 km of at least
one of the monitoring stations (Fig. 1a). Annual means
of data recorded at each monitoring station showed lim-
ited differences between stations (Fig. 1b). Clinic visita-
tions by subjects varied with season with the maximum
number of visits occurring in April (Fig. 1c). Substantial
seasonal variations were observed in the concentrations
of the air pollutants over a 12-month period (Fig. 1d). A
more detailed comparison of the pollution levels be-
tween air quality monitoring stations and years in
Additional file 1: Figure S1 shows that there is more
variability between stations than there is between
yearly averages from a single station. The results of in-
verse weighted averaging of the pollutants on January
1, 2014, over a rectangular grid covering all participant
locations are shown in Additional file 1: Figure S2, reveal-
ing that the estimate is smooth with a local extremum at
each monitoring station. The distribution of pollution ex-
posure across individuals for six different durations prior
to the visit is shown in Additional file 1: Figure S3. Be-
cause subjects did not differ substantially in their average
AAP exposure over the course of a year (as indicated by
very short boxes for this time period in Additional file 1:
Figure S3), we excluded the 365-day time period from fur-
ther analyses. We defined short-term as time periods
equal to or less than 90-day exposure. Long-term was
defined as greater than 90-day exposure.
Normalization of methylation data
Before testing our primary hypothesis, we normalized
the effects of sex, age, and BMI on Foxp3 and IL10
methylation. Figure 2 shows the relationship between
these methylation values and sex and age from 241 visits
by 198 eligible subjects, revealing a few outlier values of
Foxp3 percent methylation. Outliers were defined as
values farther than three times the interquartile range
(IQR) from the first quartile or third quartile; these
values were excluded from the analysis presented in the
main text, leaving n = 188 individuals. In the supple-
ment, we report the results we would have obtained if
we had not excluded these outliers, showing that the
main conclusions would not have changed substantially.
Figure 2a also shows that Foxp3 DMRs in females were
greater than in males and that, at the promoter sites, it
decreased with age (n = 188, p < 0.0001; Additional file 1:
Table S3). The relationship with sex is consistent with
the presence of a hypermethylated, inactive X chromo-
some. The only exception was CpG-138, which had a
higher DMR in males than in females (Additional file 1:
Figure S4). BMI may be weakly associated with Foxp3
methylation when adjusted for sex, age, and age-sex
interaction (p = 0.0523). For IL10 (n = 179, due to miss-
ing data for nine subjects), Fig. 3b indicates methylation
generally decreases with age (p < 0.0001) but is not asso-
ciated with sex.
For the rest of the analysis, we used the residuals from
fitting methylation to a regression model with the follow-
ing covariates: sex, age, BMI, and age-sex interaction. For
much of the analysis, we used averages across multiple
sites, so these residuals are divided by the estimated stand-
ard deviation of the error to obtain “normalized” methyla-
tion, giving equal weight to all sites in these averages.
Association between methylation and asthma status
We tested whether asthma was significantly associated
with normalized methylation at each CpG site studied
for Foxp3 (Fig. 3a, Additional file 1: Table S4) using an
ANOVA model. We found that asthma was significantly
associated with methylation at four of the six CpG sites
in the promoter region of Foxp3 (p < 0.05). We also
found that averaging over all six of these sites gave a
stronger association than that for any individual site, so
we used this average in the rest of the analysis. To aid in
Table 1 Demographic characteristics of study subjects*
Non-asthmatic Asthmatic
Number of subjects 121 67
Total number of male 59 (48.8%) 35 (52.2%)
Median age at enrollment (years)
(quartile 1; quartile 3)
14.7 (12.9; 16.9) 14.6 (13.1; 16.9)
Median BMI (kg/m2)
(quartile 1; quartile 3)
21.7 (19.1; 25.6) 22.0 (18.8; 28.0)
Total number of rhinitis 9 (7.8%) 12 (23.1%)
Total number of eczema 11 (9.8%) 8 (15.7%)
Total number of African-American 4 (3.0%21) 5 (7.5%)
Total number of Hispanic or Latino 72 (59.5%) 27 (40.3%)
Total number of Caucasian 34 (28.0%) 15 (22.4%)
Total number of mixed race 5 (4.1%) 3 (4.5%)
Total number of not reported 6 (5.0%) 17 (25.3%)
Total number of exposed to
secondhand smoke
12 (10.3%) 7 (12.5%)
Total number of smokers 1 (0.9%) 0 (0%)
Total number of household
income < $15,000
35 (28.9%) 15 (22.4%)
Total number of household
oncome $15,000–30,000
27 (22.3%) 12 (17.9%)
Total number of household
income $31,000–50,000
12 (9.9%) 3 (4.4%)
Total number of household
income > $50,000
35 (28.9%) 18 (26.9%)
Total number of household
income not reported
12 (9.9%) 19 (28.3%)
BMI body mass index
*Frequencies may not sum to full sample size due to missing data
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interpretation of the effect sizes in Fig. 3a, we note that
the estimated standard deviation of the error for each
sex at each CpG site in the Foxp3 promoter was gener-
ally 4–6%. Hence, an effect size of 0.3 for the normalized
values is roughly equivalent to 1.2–1.8 for percent
methylation.
Similarly, we found that asthma was significantly asso-
ciated with normalized methylation at all three CpG
sites in region 3 of intron 4 of IL10 (p < 0.05) (Fig. 3b,
Additional file 1: Table S4). Furthermore, averaging over
all three of these sites gave a stronger association than for
any individual site, so we used this average in the rest of
the analysis. The estimated standard deviation of the error
for each sex at each CpG site in IL10 was generally 9–11%.
Because the measured PBMC methylation is the average
of all constituent cell types in a sample weighted by their
proportion, an observed difference in methylation between
healthy and asthmatic subjects could potentially be an
artifact of differences in the underlying cell distribution.
Conversely, because Treg cells constitute a small percent-
age of the PBMC fraction, a large difference in methylation
within Treg could be masked by a small difference in cell
composition. To rule out these possibilities, we performed
two kinds of analyses on a random subset of the data for
which cell counts of nine different cell types were obtained
using CyTOF. First, we compared the proportion of each
cell type. The proportion of activated Tregs was found to
be statistically indistinguishable between asthmatic and
healthy subjects (p = 0.528). After multiple testing correc-
tions at a false discovery rate (FDR) of 0.05, Th17 cells were
the only type of cell among those tested with a statistically
significant difference (see Additional file 1: Table S2 for
adjusted p values). We then repeated multiple linear regres-
sion to fit the average methylation in the promoter area of
the Foxp3 gene and the average methylation of region 3 of
intron 4 of the IL10 gene. The cell type composition was
included as an additional covariate to adjust for any
differences. For IL10, there was a higher DMR of IL10
by 8.9±7.7% (p = 0.026) for asthmatic subjects.
Association between methylation and ambient air pollution
We investigated the association between AAP exposure
(CO, O3, NO2, PM2.5) and methylation of CpG sites in
the Foxp3 and IL10 genes. The general characteristics of
a b
c d
Fig. 1 Panel a shows the relative locations of the air quality monitoring stations (magenta symbols) and the participant home addresses (black
circles). Panel b illustrates the variability across monitoring stations (indicated by different symbols as in the legend), which match the shapes
of the magenta symbols in panel a for the four studied pollutants (CO, NO2, O3, PM2.5), indicated with different colors as in the legend in panel
d, using yearly averages across the study period (2010–2015); the bars show the ranges of the annual averages. Only two monitoring stations
reported values for PM2.5. Panel c describes the distribution of the 188 clinic visits across months of the calendar year, and panel d illustrates the
seasonal variation in pollutants using monthly averages across monitoring stations, with the bars showing the ranges of the monthly averages
across years 2010–2015. Note: In panels b and d, each value is divided by the average for the pollutant overall monitoring stations and years.
Also, two stations in close proximity replaced each other, so their data are combined in panels b and d; in panel a, they are indicated by two
magenta circles very close together in the middle of the plot
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our estimates of AAP exposure were described previ-
ously in this “Results” section.
To test for association with methylation, we included
one pollutant at one time period along with asthma in
the linear regression model. To control for other sea-
sonal effects such as pollen (for which we do not have a
direct measurement), we also considered including sea-
son in the model, which greatly increased p values for
pollutants. (Additional file 1: Figures S8 and S9 show
p values for all models, all pollutants, and all time pe-
riods considered.) Adding a random family effect had
little effect on p values for pollutants. Therefore, we
focused on the results from a model that included
asthma, season, and one pollutant. The p values and
effect sizes of the pollutant on averaged normalized
methylation are plotted in Fig. 4. For both genes and
all pollutants, the smallest p value for pollutant oc-
curred at the 90-day exposure duration, prior to the
blood draw. For IL10, this association was not signifi-
cant for any of the four AAPs (p > 0.1), but all were
significant (p < 0.02) for Foxp3. Table 2 shows the p
values and regression coefficients for the 90-day
a
b
Fig. 2 Foxp3 (a) and IL-10 (b) percent methylation at measured CpG sites as a function of age, grouped by sex (M/F), and asthma status (non/
asthma) as indicated. Markers of Foxp3 outliers are enclosed by black circles or squares, depending on sex. These outliers are not used in the
computation of the regression lines shown for each group
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pollution exposure prior to the blood draw and Foxp3
promoter methylation models. The p values for the
season are not significant in this model, and methyla-
tion is clearly more strongly associated with 90-day
exposure. To compare the effect sizes to each other,
we divided each AAP value by the 90th percentile of
all monitor measurements for the pollutant, which
limits the interpretability of any individual pollutant
coefficient. Finally, we also considered aggregating the
pollutants to increase power. We used only the first
principal component (PC1) of the AAP values scaled
so that each pollutant has mean zero and variance
one. PC1 accounts for 93% of their total variance; the
sign of the weight of O3 was the opposite of the sign
of the other three weights, and the absolute values of
the weights are within 4% of each other. The last row
of Table 2 shows the p values and regression coeffi-
cients for a model including PC1 along with asthma
and season. The p value for PC1 is roughly the mini-
mum of the pollutant p values in the other rows.
The p values and regression coefficients from models
analyzing the associations between 90-day average
a b
Fig. 4 The p values and effect sizes of the associations between each pollutant and normalized methylation, averaged over the sites in the
promoter of Foxp3, and over the sites in region 3 of intron 4 of IL-10. Each model also includes an effect for season and one for asthma. The
horizontal dashed lines in the p value plots indicate p = 0.05. In the plots of effect sizes, the dashed lines indicate y = 0. To compare effect sizes
across pollutants, each AAP value is divided by the 90th percentile of all sensor measurements for the pollutant
a b
Fig. 3 The p values and effect sizes from ANOVA tests of significance of asthma status on normalized methylation for the Foxp3 (a) and IL-10 (b) genes at
individual sites, and also averages over groups of sites. The horizontal dashed lines in the p value plots indicate p = 0.05. In the plots of effect sizes, the
dashed lines indicate y = 0
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pollutant exposure and normalized methylation aver-
aged over the sites in the promoter of Foxp3. Each row
is for one model that includes 90-day exposure for the
specified pollutant. Asthma and season are covariates
in every model. Since season is modeled as a factor
with four levels, it has a coefficient for each season. In
the last row, the pollutants are aggregated by their first
principal component. PC1 is scaled much differently
than the exposure values used in the other rows and its
sign is arbitrary, so we omit its coefficient.
Differences in percent methylation across repeated
testing of methylation and estimation of ambient air
pollution
In a convenience subset of the subjects, we evaluated
changes in DMRs on the Foxp3 (n = 33) and IL10 (n = 30)
genes after a period of time (mean 820 days, SD 243 days).
We evaluated whether our model could explain changes
in normalized methylation associated with exposure to
AAPs. We predicted percent methylation for each partici-
pant at the time of repeat measure using data from 188
subjects (or 179 for IL10) and average normalized methy-
lation to covariates asthma, season, and 90-day average of
exposure to a single pollutant. Additional file 1: Figure S5
compares the observed values from the second time point
to both the predicted values and to the original values for
each gene and each pollutant for the subset of subjects
with two visits. For any given individual, the actual nor-
malized values generally change between the two time
points. Furthermore, the prediction error for the second
time point is generally large, but the model does correctly
predict for most individuals whether an individual will
have higher or lower DMRs at the second time point than
at the first sample time.
Treg: Foxp3 and IL10 protein expression
Cell type and protein expression were measured by CyTOF.
The association between both activated (a result of the
PMA-ION used to stimulate IL10 cytokine production)
Tregs (CD25 high, CD127 low) in CD4+ cells and Foxp3
protein expression vs. Foxp3 methylation was analyzed at
each CpG site for the 74 subjects for which we had per-
formed CyTOF analysis. When analyzed using multivariate
linear regression with the covariates of asthma status, age,
BMI, and sex, Tregs were inversely proportional to the
average Foxp3 methylation of the CpG sites in the pro-
moter site (p = .039; Additional file 1: Figure S6a). There
was no significant association between Foxp3 methylation
and Foxp3 expression (Additional file 1: Figure S6b).
The association between IL10 cytokine expression in
CD4+ T cells and average IL10 methylation at region 3
of intron 4 was also analyzed for a subset of subjects
with available cytokine data (n = 53). When analyzed
using multivariate linear regression with the covariates
of asthma status, age, BMI, and sex, IL10 cytokine ex-
pression was positively associated with IL10 methylation
(p = 0.030; Additional file 1: Figure S6c).
Discussion
In this cohort study of children from Fresno, an area lo-
cated in the San Joaquin Valley of California and known
for high AAP exposure, we examined DMRs of Foxp3
and IL10, which are genes involved in immune tolerance
[28, 29]. Foxp3 plays a key role in maintaining tolerance
to common antigens in asthma and allergy [30]. IL10 se-
cretion by T cells can promote tolerance and suppress
the production of IgE by B cells [29]. Additionally, prior
studies have found an association between exposure to
AAPs and Foxp3 or IL10 modifications [14, 31]. Overall,
the results were consistent with our primary hypothesis
(i.e., higher DMR with increased pollution exposure).
Our results indicate that DMRs in the Foxp3 promoter
and IL10 intronic regions are preferentially methylated
in asthmatic patients. These results are supported by
other studies that have similarly found DNA methylation
differences between asthmatic and control subjects at
CpG loci in other genes [10, 32]. However, this DMR
may be associated with asthma, regardless of the time
point of pollution exposure. Furthermore, recent work
indicates that heritable epigenetic alterations may mediate
the increasing prevalence of atopic diseases [33, 34]. These
epigenetic markers may serve as potential biomarkers to
support clinical diagnosis.
Several variables measured in this study have been
shown to be associated with asthma, such as age, BMI,
and sex. We therefore adjusted for these factors in our
Table 2 p values and regression coefficients for 90-day pollution exposure prior to blood draw and Foxp3 promoter methylation
models
Asthma Pollutant Season
Pollutant in model p Coef p Coef p Spring Summer Autumn Winter
CO 0.008 0.283 0.001 1.157 0.400 − 0.828 − 0.863 − 0.858 − 1.140
NO2 0.010 0.276 0.001 1.504 0.287 − 0.957 − 0.852 − 1.052 − 1.277
O3 0.011 0.275 0.002 − 2.158 0.437 1.045 1.436 1.444 0.829
PM2.5 0.016 0.261 0.012 0.903 0.145 − 0.445 − 0.608 − 0.665 − 0.770
PC1 0.011 0.273 0.001 NA 0.331 − 0.075 0.034 − 0.051 − 0.442
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analyses and found that exposure to AAPs is associated
with increased DMRs in the promoter region of Foxp3.
These results are consistent with prior studies that have
demonstrated that the Foxp3 gene is involved in overall im-
mune tolerance [28], and more specifically that Tregs,
which are suppressors of immune responses involved in
asthma pathogenesis, are impaired in pediatric asthma [35].
Foxp3 can also be present in activated CD4+ T effector
cells; therefore, its presence is not a sine qua non of a Treg.
We have also shown in two prior studies that increased
exposure to ambient PAHs is associated with generalized
higher differential DMR of the Foxp3 locus [8, 14].
This study provides novel information by identifying
specific gene regions that are sensitive to AAPs. We
evaluated methylation at the enhancer and promoter re-
gions of the Foxp3 gene. We found methylation at the
upstream promoter region of Foxp3 to be associated
with both asthma status and exposure to AAPs. How-
ever, we found no correlation between methylation and
asthma status at the enhancer region. Importantly, our
findings of a positive association between AAP exposure
and Foxp3 methylation in our initial cross-sectional ana-
lyses were consistent with the results of our longitudinal
analyses in a subset of subjects.
We also found that individual pollutants differ in their
effects on CpG methylation. Exposure to higher levels of
NO2, CO, and PM2.5 are associated with higher DMRs
of the promoter region of the Foxp3 gene. However, O3
exposure was inversely associated with Foxp3 methyla-
tion. This is not surprising as O3 is a regional pollutant
with a seasonal pattern opposite to that of the other
pollutants (Additional file 1: Figure S7), and we may not
be observing the effect of high ozone on methylation,
but, rather, the fact that the other pollutants were low.
This is the first study to our knowledge that has evalu-
ated the association between IL10 methylation and air
pollution. We found that DMRs in the intronic region 3
are preferentially methylated in patients with asthma.
However, we did not find significant associations be-
tween AAP and intron 4 methylation. In future studies,
additional CpG sites, such as those in the promoter region
of IL10, could be evaluated.
While previous investigations have suggested that ex-
posure to higher levels of AAPs are associated with in-
creased prevalence of asthma and allergy [36–39] and
that protein expression of IL10 decreased as PAH expos-
ure increased from 24 h to 1 year [14], previous studies
have not specified a critical time of exposure duration.
Here, we determined that there was a significant positive
association of Foxp3 promoter methylation and pollution
for all subjects when there was exposure to certain AAPs
(NO2, CO, and PM2.5) over the previous 90 days prior to
the blood draw. In addition, AAP exposure averaged
over the 90 days was more strongly associated with
Foxp3 methylation than it was with season. For the IL10
gene, there was not a significant association between
pollutant exposure levels and the amount of intro region
methylation, prompting our suggestion that additional
IL10 gene regions be evaluated in future studies.
By using CyToF, we were able to link methylation and
protein levels in high dimensional cell immune monitor-
ing for these subjects. In addition, we demonstrated that
methylation of the promoter region of the Foxp3 gene is
negatively associated with activated Treg levels, and IL10
methylation at region 3 of intron 4 is positively associ-
ated with IL10 cytokine expression. Foxp3 is produced
by both Treg and activated T cells. However, IL10 is
synthesized by many immune cells and given there was
a wide standard of error, it is difficult to comment on
the biological significance of the IL10 results.
We also recognize that our study is subject to a number
of limitations. Blood collection occurred across all four
seasons, and visits were not evenly distributed within each
season. It is possible that the visit peak in April is driven by
seasonal variations in airborne pollen and that the regres-
sion analyses might not remove the impact of this effect.
The 90-day exposure finding could represent opposing
effects (pollen/pollutant seasonal variations), which negate
each other so that pollutant exposure impact can be de-
tected. Future analyses are planned to address this. Not
only do the AAP pollutants vary by season, aeroallergens
such as ragweed, oak/maple, and Pinaceae pollen can affect
the severity of asthma and pediatric asthma emergency
department and clinic visits and have been shown to be as-
sociated with daily aeroallergen concentrations [40]. Repeat
visits are limited in number and did not necessarily occur
in the same season. To compensate, seasonality was
included in the models used to investigate associations
between methylation and AAP exposure, and 90-day
exposure prior to the blood draw had a stronger effect than
season, but simply using four seasons to model seasonality
might not accurately reflect actual pollen levels in a given
year. Furthermore, individual exposure was evaluated with
the inverse distance weighting (IDW) method, rather than
directly measured [25, 26]. It is also possible that other
pollutants, dietary exposure, and toxins from the air, water,
and other sources, not measured in this study, may
contribute to DNA methylation. The generalizability of the
results may be limited because the population was predom-
inantly Hispanic and a convenience sample. And ethnicity
was not adjusted in the models. Asthma was defined by
self-report of physician diagnosis of asthma, rather than by
clinical testing. However, in publications using the same
technique, it was found that the agreement of patient self-
report and physician diagnosis was correlated [41] with the
questions about “physician-diagnosed asthma” having a
specificity of 99% [42]; therefore, we used this method as
part of our study definition of asthma. Our failure to find a
Prunicki et al. Clinical Epigenetics  (2018) 10:2 Page 9 of 11
significant association between Foxp3 protein expression
and Foxp3 methylation may be related to the ongoing de-
bate whether all Treg are Foxp3 positive or whether all
Foxp3 positive T cells are Treg or if transcription and pro-
tein expression are directly related in Treg [43]. Given that
the Treg population is a small fraction of the overall cell
count, the measurement of Foxp3 protein expression may
be lost in the margin of error when measuring both it and
the percentage of Tregs.
In summary, our data demonstrate that (1) CpG
methylation in the promoter region of Foxp3 and in the
intronic region of IL10 is greater in asthmatic than non-
asthmatic subjects; (2) methylation levels at specific
CpG sites in the Foxp3 promoter region are associated
with level of exposure to the pollutants CO, NO2, PM2.5,
and O3 over the previous 90 days prior to the blood
draw; and (3) activated Treg levels are negatively associ-
ated with average Foxp3 methylation in the promoter
region, and IL10 methylation at region 3 of intron 4 is
positively associated with IL10 cytokine expression. The
findings from this study increase our understanding of
the epigenetic effects of exposure to AAPs and may im-
pact the development of preventative regimens and/or
therapies to alter methylation of these sites and possibly
prevent asthma associated with AAP exposure [44].
Conclusion
Our study suggests that asthma is significantly associated
with higher DMRs within the promoter region of Foxp3 as
well as region 3 of intron 4 of IL10. In addition, DMRs in
the promoter region of Foxp3 are positively linked with
average exposure to CO, NO2, and PM2.5 during the 90 days
prior to the blood draw. These findings may provide im-
portant insight into understanding how pollution could
exert detrimental effects relating to asthma, but need to be
confirmed in future studies. Ultimately, this research may
be useful in elucidating epigenetic biomarkers of asthma
and in developing therapeutic targets by which to prevent
or correct epigenetic damage resulting from pollution.
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